BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grubor-Bauk B, Wijesundara DK, Masavuli M, Abbink P, Peterson RL, Prow NA, Larocca RA, Mekonnen ZA, Shrestha A, Eyre NS, Beard MR, Gummow J, Carr J, Robertson SA, Hayball JD, Barouch DH, Gowans EJ. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice. Sci Adv 2019;5:eaax2388. [PMID: 31844662 DOI: 10.1126/sciadv.aax2388] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Adam A, Lee C, Wang T. Rational Development of Live-Attenuated Zika Virus Vaccines. Pathogens 2023;12. [PMID: 36839466 DOI: 10.3390/pathogens12020194] [Reference Citation Analysis]
2 Dahiya N, Yadav M, Singh H, Jakhar R, Sehrawat N. ZIKV: Epidemiology, infection mechanism and current therapeutics. Front Trop Dis 2023;3. [DOI: 10.3389/fitd.2022.1059283] [Reference Citation Analysis]
3 Waldran MJ, Wegman AD, Bahr LE, Currier JR, Waickman AT. Soluble NS1 antagonizes IgG- and IgA-mediated monocytic phagocytosis of DENV infected cells.. [DOI: 10.1101/2022.12.17.520876] [Reference Citation Analysis]
4 Shin M, Kim K, Lee HJ, Jung YJ, Park J, Hahn TW. Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice. Trop Med Health 2022;50:91. [PMID: 36471432 DOI: 10.1186/s41182-022-00485-6] [Reference Citation Analysis]
5 Xiong G, Li Y, Chen F, Xiong X, Wang Q, Zhang L, Dong H, Zhu C, Cui J, He M, Cheng H, Hu A, Cheng C, Pang J, Liu G, Chen H. Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E. International Immunopharmacology 2022;113:109308. [DOI: 10.1016/j.intimp.2022.109308] [Reference Citation Analysis]
6 Wang Y, Ling L, Zhang Z, Marin-Lopez A. Current Advances in Zika Vaccine Development. Vaccines (Basel) 2022;10. [PMID: 36366325 DOI: 10.3390/vaccines10111816] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Cheong HC, Cheok YY, Chan YT, Sulaiman S, Looi CY, Alshanon AF, Hassan J, Abubakar S, Wong WF. Zika Virus Vaccine: The Current State of Affairs and Challenges Posed by Antibody-Dependent Enhancement Reaction. Viral Immunology 2022. [DOI: 10.1089/vim.2022.0082] [Reference Citation Analysis]
8 Zhu L, Liu S, Zhuo Z, Lin Y, Zhang Y, Wang X, Kong L, Wang T. Expression and immunogenicity of nsp10 protein of porcine epidemic diarrhea virus. Res Vet Sci 2022;144:34-43. [PMID: 35038674 DOI: 10.1016/j.rvsc.2021.12.024] [Reference Citation Analysis]
9 Kurup D, Wirblich C, Lambert R, Diba LZ, Leiby BE, Schnell MJ. Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. NPJ Vaccines 2022;7:43. [PMID: 35440656 DOI: 10.1038/s41541-022-00464-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Guzeloglu-kayisli O, Kayisli UA, Schatz F, Lockwood CJ. Vertical Zika Virus Transmission at the Maternal-Fetal Interface. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.801778] [Reference Citation Analysis]
11 Alves AMB, Costa SM, Pinto PBA. Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge? Front Med Technol 2021;3:640964. [PMID: 35047911 DOI: 10.3389/fmedt.2021.640964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shin M, Kim K, Lee HJ, Lee R, Jung YJ, Park J, Hahn TW. Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice. Sci Rep 2022;12:660. [PMID: 35027643 DOI: 10.1038/s41598-021-04713-7] [Reference Citation Analysis]
13 Cuevas-Juárez E, Pando-Robles V, Palomares LA. Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives. Vaccine 2021;39:6990-7000. [PMID: 34753613 DOI: 10.1016/j.vaccine.2021.10.049] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Nazerai L, Buus S, Stryhn A, Thomsen AR, Christensen JP. Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain. Viruses 2021;13:2215. [PMID: 34835021 DOI: 10.3390/v13112215] [Reference Citation Analysis]
15 Zhou K, Li C, Shi W, Hu X, Nandakumar KS, Jiang S, Zhang N. Current Progress in the Development of Zika Virus Vaccines. Vaccines (Basel) 2021;9:1004. [PMID: 34579241 DOI: 10.3390/vaccines9091004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Sun J, Zheng Z, Li M, Liu Z, Su X, Jin X. Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice. Vaccine 2021;39:5173-86. [PMID: 34353682 DOI: 10.1016/j.vaccine.2021.07.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Carpio KL, Barrett ADT. Flavivirus NS1 and Its Potential in Vaccine Development. Vaccines (Basel) 2021;9:622. [PMID: 34207516 DOI: 10.3390/vaccines9060622] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
18 Crooke SN, Ovsyannikova IG, Kennedy RB, Poland GA. Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects. PLoS One 2021;16:e0252198. [PMID: 34077451 DOI: 10.1371/journal.pone.0252198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Gambino F Jr, Tai W, Voronin D, Zhang Y, Zhang X, Shi J, Wang X, Wang N, Du L, Qiao L. A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage. Cell Rep 2021;35:109107. [PMID: 33979612 DOI: 10.1016/j.celrep.2021.109107] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
20 Wan J, Wang T, Xu J, Ouyang T, Wang Q, Zhang Y, Weng S, Li Y, Wang Y, Xin X, Wang X, Li S, Kong L. Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit. EBioMedicine 2021;67:103353. [PMID: 33971403 DOI: 10.1016/j.ebiom.2021.103353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
21 Watterson D, Wijesundara DK, Modhiran N, Mordant FL, Li Z, Avumegah MS, McMillan CL, Lackenby J, Guilfoyle K, van Amerongen G, Stittelaar K, Cheung ST, Bibby S, Daleris M, Hoger K, Gillard M, Radunz E, Jones ML, Hughes K, Hughes B, Goh J, Edwards D, Scoble J, Pearce L, Kowalczyk L, Phan T, La M, Lu L, Pham T, Zhou Q, Brockman DA, Morgan SJ, Lau C, Tran MH, Tapley P, Villalón-Letelier F, Barnes J, Young A, Jaberolansar N, Scott CA, Isaacs A, Amarilla AA, Khromykh AA, van den Brand JM, Reading PC, Ranasinghe C, Subbarao K, Munro TP, Young PR, Chappell KJ. Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clin Transl Immunology 2021;10:e1269. [PMID: 33841880 DOI: 10.1002/cti2.1269] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
22 Estévez-Herrera J, Pérez-Yanes S, Cabrera-Rodríguez R, Márquez-Arce D, Trujillo-González R, Machado JD, Madrid R, Valenzuela-Fernández A. Zika Virus Pathogenesis: A Battle for Immune Evasion. Vaccines (Basel) 2021;9:294. [PMID: 33810028 DOI: 10.3390/vaccines9030294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Lee YH, Lim H, Lee JA, Kim SH, Hwang YH, In HJ, Kim MY, Chung GT. Optimization of Zika DNA vaccine by delivery systems. Virology 2021;559:10-4. [PMID: 33780719 DOI: 10.1016/j.virol.2021.03.005] [Reference Citation Analysis]
24 Dey D, Poudyal S, Rehman A, Hasan SS. Structural and biochemical insights into flavivirus proteins. Virus Res 2021;296:198343. [PMID: 33607183 DOI: 10.1016/j.virusres.2021.198343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
25 Manna S, Dey S, Biswas S, Nandy A, Basak SC. Current Perspective of Zika Virus and Vaccine Development. Exploratory Research and Hypothesis in Medicine 2020;000:1-9. [DOI: 10.14218/erhm.2020.00060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Pereira LR, Alves RPDS, Sales NS, Andreata-Santos R, Venceslau-Carvalho AA, Pereira SS, Castro-Amarante MF, Rodrigues-Jesus MJ, Favaro MTP, Chura-Chambi RM, Morganti L, Ferreira LCS. Enhanced Immune Responses and Protective Immunity to Zika Virus Induced by a DNA Vaccine Encoding a Chimeric NS1 Fused With Type 1 Herpes Virus gD Protein. Front Med Technol 2020;2:604160. [PMID: 35047887 DOI: 10.3389/fmedt.2020.604160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Mekonnen ZA, Masavuli MG, Yu W, Gummow J, Whelan DM, Al-Delfi Z, Torresi J, Gowans EJ, Grubor-Bauk B. Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3. Front Microbiol 2020;11:559105. [PMID: 33343515 DOI: 10.3389/fmicb.2020.559105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Elong Ngono A, Syed T, Nguyen AV, Regla-Nava JA, Susantono M, Spasova D, Aguilar A, West M, Sparks J, Gonzalez A, Branche E, DeHart JL, Vega JB, Karmali PP, Chivukula P, Kamrud K, Aliahmad P, Wang N, Shresta S. CD8+ T cells mediate protection against Zika virus induced by an NS3-based vaccine. Sci Adv 2020;6:eabb2154. [PMID: 33148638 DOI: 10.1126/sciadv.abb2154] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
29 Bos S, Poirier-Beaudouin B, Seffer V, Manich M, Mardi C, Desprès P, Gadea G, Gougeon ML. Zika Virus Inhibits IFN-α Response by Human Plasmacytoid Dendritic Cells and Induces NS1-Dependent Triggering of CD303 (BDCA-2) Signaling. Front Immunol 2020;11:582061. [PMID: 33193389 DOI: 10.3389/fimmu.2020.582061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kurup D, Wirblich C, Schnell MJ. Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract in the hCD46 IFNα/β receptor knockout mice.. [DOI: 10.1101/2020.09.17.301622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Li A, Xue M, Attia Z, Yu J, Lu M, Shan C, Liang X, Gao TZ, Shi PY, Peeples ME, Boyaka PN, Liu SL, Li J. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection. J Virol 2020;94:e00048-20. [PMID: 32554698 DOI: 10.1128/JVI.00048-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Li N, Zhang ZR, Zhang YN, Liu J, Deng CL, Shi PY, Yuan ZM, Ye HQ, Zhang B. A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice. NPJ Vaccines 2020;5:73. [PMID: 32802412 DOI: 10.1038/s41541-020-00220-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
33 Campbell VL, Nguyen L, Snoey E, McClurkan CL, Laing KJ, Dong L, Sette A, Lindestam Arlehamn CS, Altmann DM, Boyton RJ, Roby JA, Gale M Jr, Stone M, Busch MP, Norris PJ, Koelle DM. Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination. Immunohorizons 2020;4:444-53. [PMID: 32753403 DOI: 10.4049/immunohorizons.2000068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
34 In HJ, Lee YH, Jang S, Lim HJ, Kim MY, Kim JA, Yoo JS, Chung GT, Kim YJ. Enhanced effect of modified Zika virus E antigen on the immunogenicity of DNA vaccine. Virology 2020;549:25-31. [PMID: 32818729 DOI: 10.1016/j.virol.2020.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Pattnaik A, Sahoo BR, Pattnaik AK. Current Status of Zika Virus Vaccines: Successes and Challenges. Vaccines (Basel) 2020;8. [PMID: 32486368 DOI: 10.3390/vaccines8020266] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
36 Subramaniam KS, Lant S, Goodwin L, Grifoni A, Weiskopf D, Turtle L. Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design. Front Immunol 2020;11:517. [PMID: 32269575 DOI: 10.3389/fimmu.2020.00517] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
37 Zheng S. The symptoms and treatment of Zika virus infection. E3S Web Conf 2020;218:03048. [DOI: 10.1051/e3sconf/202021803048] [Reference Citation Analysis]